HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$47.49
Day range
$47.22 - $48.76
Year range
$19.83 - $94.75
Market cap
5.72B USD
Avg Volume
1.40M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 146.38M | 545.89% |
Operating expense | 141.70M | 67.96% |
Net income | -88.58M | 46.64% |
Net profit margin | -60.51 | 91.74% |
Earnings per share | -0.73 | 51.33% |
EBITDA | -84.04M | 48.65% |
Effective tax rate | -1.63% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 355.54M | -36.32% |
Total assets | 788.73M | 3.75% |
Total liabilities | 594.21M | 0.65% |
Total equity | 194.52M | — |
Shares outstanding | 120.58M | — |
Price to book | 29.13 | — |
Return on assets | -26.30% | — |
Return on capital | -65.29% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -88.58M | 46.64% |
Cash from operations | -97.88M | 30.46% |
Cash from investing | 4.00K | -100.00% |
Cash from financing | -3.91M | 75.46% |
Net change in cash | -101.20M | -212.60% |
Free cash flow | -49.07M | 29.28% |
About
Founded
2009
Headquarters
Website
Employees
704